Takeda Shares Plunge on Damages Verdict

April 8 (Bloomberg) –- Bloomberg’s David Ingles reports on Takeda Pharmaceuticals shares plunging in Tokyo after the company was ordered to pay $6B in punitive damages after losing it’s first Federal trial over it’s Actos diabetes drug. He speaks to Rishaad Salamat on Bloomberg Television’s “Asia Edge.” (Source: Bloomberg)
HSBC Said to Be Considering Sale of Retail Unit
39:02 - HSBC is reportedly interested in selling its retail unit. Bloomberg’s Stephen Engle reports on “Coundown.” (Source: Bloomberg)
  • Google, Facebook Offer Tools for Quake Victims
  • Water, Power Supply Are Concerns After Nepal Quake: Meyer
  • Quake Impact Could Exceed 20% of GDP: IHS